ID

23709

Beschreibung

Responsible Party: Stephan Ehrhardt, Lead investigator, Bernhard Nocht Institute for Tropical Medicine ClinicalTrials.gov Identifier: NCT01143272 History of Changes Other Study ID Numbers: BNI-2009-01 2009-017374 [Titel anhand dieser ISBN in Citavi-Projekt übernehmen] -20 ( EudraCT Number ) ISRCTN01005546 ( Registry Identifier: ISRCTN, http://www.controlled-trials.com/ISRCTN01005546 ) DRKS00000084 ( Registry Identifier: Deutsches Register Klinischer Studien ) Study First Received: June 11, 2010 Results First Received: March 17, 2016 Last Updated: June 7, 2016 Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (SacBo) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01143272

Link

http://www.controlled-trials.com/ISRCTN01005546

Stichworte

Versionen (1)
  1. 11.07.17 11.07.17 -
Hochgeladen am

11. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Antibiotic-associated Diarrhoea NCT01143272 DRKS00000084

Englisch

Eligibility Antibiotic-associated Diarrhoea NCT01143272 DRKS00000084

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Adult patient (≥ 18 years)
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Patient hospitalized
Beschreibung

Hospitalization

Datentyp

boolean

Alias
UMLS CUI [1]
C0019993
Patient receives systemic antibiotic treatment
Beschreibung

Systemic antibiotic treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C3540704
Patient contractually capable
Beschreibung

Legal competency

Datentyp

boolean

Alias
UMLS CUI [1]
C0680554
Patient able to follow study procedures
Beschreibung

Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
Informed consent of patient
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Healthy Volunteers
Beschreibung

Control Group

Datentyp

boolean

Alias
UMLS CUI [1]
C0009932
allergy against yeast and/or Perenterol® forte und/oder placebos containing Saccharomyces cerevisiae HANSEN CBS 5926, lactose-monohydrate, magnesium stearate, gelatine, sodium dodecyl sulfate, titan dioxide, microcrystalline cellulose.
Beschreibung

Hypersensitivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
Central venous catheter
Beschreibung

Central venous catheter

Datentyp

boolean

Alias
UMLS CUI [1]
C1145640
Immunosuppression
Beschreibung

Immunosuppression

Datentyp

boolean

Alias
UMLS CUI [1]
C0021079
Diarrhoea and/or chronic diarrhoea
Beschreibung

Diarrhea

Datentyp

boolean

Alias
UMLS CUI [1]
C0011991
Regular intake of Perenterol®, Perenterol® forte oder Yomogi® in the last seven days before the start of the study
Beschreibung

Pharmacotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0013216
Systemic antimycotic treatment
Beschreibung

Systemic antimycotic treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C3653762
Systemic antibiotic treatment within the last 6 weeks
Beschreibung

Prior Antibiotic Treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003232
UMLS CUI [1,2]
C1514463
No protection against conception, pregnancy, or lactation
Beschreibung

Gynaecological Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
Simultaneous participation in other clinical trials
Beschreibung

Study Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Antibiotic-associated Diarrhoea NCT01143272 DRKS00000084

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
Adult patient (≥ 18 years)
boolean
C0001779 (UMLS CUI [1])
Hospitalization
Item
Patient hospitalized
boolean
C0019993 (UMLS CUI [1])
Systemic antibiotic treatment
Item
Patient receives systemic antibiotic treatment
boolean
C3540704 (UMLS CUI [1])
Legal competency
Item
Patient contractually capable
boolean
C0680554 (UMLS CUI [1])
Compliance
Item
Patient able to follow study procedures
boolean
C1321605 (UMLS CUI [1])
Informed consent
Item
Informed consent of patient
boolean
C0021430 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Hypersensitivity
Item
allergy against yeast and/or Perenterol® forte und/oder placebos containing Saccharomyces cerevisiae HANSEN CBS 5926, lactose-monohydrate, magnesium stearate, gelatine, sodium dodecyl sulfate, titan dioxide, microcrystalline cellulose.
boolean
C0020517 (UMLS CUI [1])
Central venous catheter
Item
Central venous catheter
boolean
C1145640 (UMLS CUI [1])
Immunosuppression
Item
Immunosuppression
boolean
C0021079 (UMLS CUI [1])
Diarrhea
Item
Diarrhoea and/or chronic diarrhoea
boolean
C0011991 (UMLS CUI [1])
Pharmacotherapy
Item
Regular intake of Perenterol®, Perenterol® forte oder Yomogi® in the last seven days before the start of the study
boolean
C0013216 (UMLS CUI [1])
Systemic antimycotic treatment
Item
Systemic antimycotic treatment
boolean
C3653762 (UMLS CUI [1])
Prior Antibiotic Treatment
Item
Systemic antibiotic treatment within the last 6 weeks
boolean
C0003232 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Gynaecological Status
Item
No protection against conception, pregnancy, or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Study Participation Status
Item
Simultaneous participation in other clinical trials
boolean
C2348568 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video